Cell Source, Inc. (CLCS): Total Assets
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$286.5K
As of 2024-12-31
$292.4K
As of 2025-03-31
-3.0%
3-year compound annual growth
+20.1%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $286.5K | +46.8% | 2026-04-07, Balance as of period end |
| 2023-12-31 | $195.2K | -52.4% | 2026-04-07, Balance as of period end |
| 2022-12-31 | $409.8K | +30.6% | 2024-06-24, Balance as of period end |
| 2021-12-31 | $313.8K | -30.6% | 2023-08-08, Balance as of period end |
| 2020-12-31 | $452.3K | +294.1% | 2022-04-15, Balance as of period end |
| 2019-12-31 | $114.8K | +74.5% | 2021-04-15, Balance as of period end |
| 2018-12-31 | $65.8K | -87.6% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $531.7K | +151.9% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $211.1K | -1.7% | 2018-07-25, Balance as of period end |
| 2015-12-31 | $214.8K | n/c | 2018-07-25, Balance as of period end |
| 2014-12-31 | $123.1K | +33.5% | 2016-04-14, Balance as of period end |
| 2013-12-31 | $92.2K | n/a | 2015-03-13, Balance as of period end |